Stock Scorecard



Stock Summary for Tango Therapeutics Inc (TNGX) - $7.33 as of 4/26/2024 3:51:38 PM EST

Total Score

10 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for TNGX

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for TNGX

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for TNGX

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for TNGX

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for TNGX

Tango Therapeutics, Inc. ( TNGX ) Reports Q4 Loss, Lags Revenue Estimates 3/18/2024 12:10:00 PM
MeiraGTx Holdings PLC ( MGTX ) Reports Q4 Loss, Misses Revenue Estimates 3/14/2024 1:45:00 PM
Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline at the American Association for Cancer Research ( AACR ) Annual Meeting 2024 - Tango Therapeutics ( NASDAQ:TNGX ) 3/5/2024 9:47:00 PM
Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline at the American Association for Cancer Research ( AACR ) Annual Meeting 2024 3/5/2024 9:47:00 PM
Tango Therapeutics to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference - Tango Therapeutics ( NASDAQ:TNGX ) 1/31/2024 12:00:00 PM
Tango Therapeutics to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference 1/31/2024 12:00:00 PM
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635 ( c ) ( 4 ) 1/5/2024 9:05:00 PM
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635 ( c ) ( 4 ) - Tango Therapeutics ( NASDAQ:TNGX ) 1/5/2024 9:05:00 PM
3 Cancer-Focused Biotechs That Appear Promising Bets for 2024 12/21/2023 2:23:00 PM
Wall Street Analysts Predict an 110.53% Upside in Tango Therapeutics, Inc. ( TNGX ) : Here's What You Should Know 12/8/2023 2:55:00 PM

Financial Details for TNGX

Company Overview

Ticker TNGX
Company Name Tango Therapeutics Inc
Country USA
Description N/A
Sector Name REAL ESTATE & CONSTRUCTION
Industry Name BLANK CHECKS
Most Recent Quarter 12/31/2023
Next Earnings Date 6/5/2024

Stock Price History

Last Day Price 7.33
Last Day Price Updated 4/26/2024 3:51:38 PM EST
Last Day Volume 0
Average Daily Volume 682,150
52-Week High 13.03
52-Week Low 2.47
Last Price to 52 Week Low 196.76%

Valuation Measures

Trailing PE N/A
Industry PE 86.53
Sector PE 64.69
5-Year Average PE -400.59
Free Cash Flow Ratio 1.29
Industry Free Cash Flow Ratio 263.47
Sector Free Cash Flow Ratio 172.38
Current Ratio Most Recent Quarter 7.54
Total Cash Per Share 5.69
Book Value Per Share Most Recent Quarter 2.48
Price to Book Ratio 3.10
Industry Price to Book Ratio 3.03
Sector Price to Book Ratio 3.49
Price to Sales Ratio Twelve Trailing Months 21.50
Industry Price to Sales Ratio Twelve Trailing Months 0.54
Sector Price to Sales Ratio Twelve Trailing Months 3.47

Share Statistics

Total Shares Outstanding 106,718,000
Market Capitalization 782,242,940
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 5.95%
Reported EPS 12 Trailing Months -1.08
Reported EPS Past Year 0.00
Reported EPS Prior Year -1.10
Net Income Twelve Trailing Months -101,744,000
Net Income Past Year -101,744,000
Net Income Prior Year -108,176,000
Quarterly Revenue Growth YOY -15.30%
5-Year Revenue Growth 68.35%

Balance Sheet

Total Cash Most Recent Quarter 607,385,000
Total Cash Past Year 607,385,000
Total Cash Prior Year 672,298,000
Net Cash Position Most Recent Quarter 607,385,000
Net Cash Position Past Year 607,385,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 253,108,000
Total Stockholder Equity Prior Year 249,476,000
Total Stockholder Equity Most Recent Quarter 253,108,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.43
MACD Signal -0.57
20-Day Bollinger Lower Band 6.26
20-Day Bollinger Middle Band 9.93
20-Day Bollinger Upper Band 13.60
Beta 0.84
RSI 40.76
50-Day SMA 7.68
200-Day SMA 0.00

System

Modified 4/27/2024 1:08:56 PM EST